A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

There’s been talk of GLP-1 and semaglutide drugs, like Ozempic, causing hair loss, but there’s no evidence yet that thinning ...

Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Nimacimab achieved significant dose-dependent weight loss of up to 16% compared ... and patent prosecution for the nimacimab IP. These costs were offset by a period over period decrease in litigation ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...